Skip to main content
Premium Trial:

Request an Annual Quote

Renovis Taps Co-founder to be CEO, Adds Two New Executive Positions

NEW YORK, Aug. 21 – Genomics-based neuroscience startup Renovis has appointed Corey Goodman to the position of president, CEO, and member of the board of directors, the company said Tuesday.

Goodman, a neuroscientist at the University of California, Berkeley, and investigator with the Howard Hughes Medical Institute, co-founded Renovis in February 2000 with several other neuroscientists. He has previously served the company only in an advisory capacity, but will assume his new executive position on September 1.

Renovis’ acting president and chief operating officer, Lynne Zydowsky, who also co-founded the company, will continue to serve as COO, but will also assume the role of senior vice president, business development, on September 1. 

In addition, the company created two new executive positions, naming Tito Serafini chief discovery scientist and vice president for genomic research, and Andrew Shyjan vice president, molecular biology.

Serafini, previously a neurobiologist at the University of California, Berkeley, is also a co-founder of Renovis. Shyjan has served as senior director for cancer research at Incyte Genomics and director of oncology at Millenium Pharmaceuticals.

Renovis, based in South San Francisco, Calif., studies gene expression profiles in neuronal cell types to identify drug targets associated with neuronal regeneration, pain, behavioral disorders, and psychiatric diseases. The company raised $16.4 million in venture capital last year and employs 37 people.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.